Granulocyte Colony-Stimulating Factor Promotes Atherosclerosis in High-Fat Diet Rabbits

Zhaohui Hu, Jie Zhang, Aili Guan, Hui Gong, Ming Yang, Guoping Zhang, Jianguo Jia, Hong Ma, Chunjie Yang, Junbo Ge, Yunzeng ZouInternational Journal of Molecular Sciences 2013 · DOI

TL;DR

This study reveals that Granulocyte Colony-Stimulating Factor (G-CSF), while potentially beneficial for heart repair, actually worsens atherosclerosis in rabbits fed a high-fat diet. G-CSF exacerbates lipid abnormalities and endothelial cell damage, suggesting it could be a risk factor for atherosclerosis, particularly in individuals with hyperlipidemia.

What Problem Does This Paper Address?

G-CSF is known to promote stem cell mobilization and has shown promise in repairing heart damage after myocardial infarction. However, its role in atherosclerosis, a chronic inflammatory disease of the arteries, has been unclear, with some clinical studies showing conflicting results. Given that atherosclerosis is a major contributor to cardiovascular disease and often co-exists with hyperlipidemia, understanding G-CSF's impact in this context is crucial for its safe and effective clinical application. This paper aims to clarify whether G-CSF's effects on atherosclerosis differ in the presence or absence of hyperlipidemia.

Methods

The researchers utilized a rabbit model of atherosclerosis. Six-month-old male New Zealand white rabbits were divided into four groups:

  • Normal diet + Vehicle: Control group on a standard diet.
  • Normal diet + G-CSF: Standard diet with G-CSF treatment.
  • High-fat diet + Vehicle: Atherosclerosis-prone group on a diet with 1% cholesterol and 5% lard.
  • High-fat diet + G-CSF: Atherosclerosis-prone group with G-CSF treatment.

The high-fat diet was administered for 10 weeks. G-CSF was injected subcutaneously for the first 3 weeks. Key analyses included:

  • Morphological Analysis: Sudan III staining to quantify atherosclerotic lesion area in the thoracic aorta. Hematoxylin-eosin (HE) staining and electron microscopy (scanning and transmission) to examine ultrastructural changes in endothelial cells.
  • Biochemical Analysis: Measurement of plasma lipid levels (Total Cholesterol - TC, Triglycerides - TG, LDL-C, HDL-C) and White Blood Cell (WBC) counts.
  • In Vitro Studies: Isolation and culture of aortic endothelial cells (ECs) to assess the effects of G-CSF and oxidized LDL (OX-LDL) on apoptosis and gene expression.
  • Apoptosis Analysis: TUNEL assay on both aortic tissue and cultured ECs to quantify cell death.
  • Gene Expression Analysis: Real-time RT-PCR to measure the mRNA levels of endothelin-1 (ET-1) and endothelial nitric oxide synthase (eNOS).

Datasets

Not discussed in the paper. The study utilized experimental animal models and in vitro cell cultures.

Key Insights and Ideas

  • G-CSF as an Atherosclerosis Promoter in Hyperlipidemia: The most striking finding is that G-CSF, when combined with a high-fat diet, significantly worsens atherosclerosis. This directly contradicts its potential role in cardiovascular repair and highlights a critical context-dependent effect.
  • Dual Impact on Lipids and Endothelium: G-CSF not only increased plasma levels of TC and LDL-C in the early stages of the high-fat diet but also severely damaged the arterial endothelium, promoting apoptosis. This suggests a multi-pronged attack on the vascular system.
  • ET-1/eNOS Imbalance: The study identified a key molecular mechanism: G-CSF promoted the expression of ET-1 (a vasoconstrictor and pro-atherogenic molecule) and decreased the expression of eNOS (which produces protective nitric oxide). This imbalance in the ET-1/eNOS system appears to be central to G-CSF's detrimental effects on endothelial function.
  • Context Matters for G-CSF: The paper strongly suggests that the beneficial effects of G-CSF seen in some cardiac repair studies might be masked or reversed in the presence of hyperlipidemia, a common comorbidity in cardiovascular disease.

Key Results

  • Increased Lesion Area: G-CSF treatment in high-fat diet rabbits led to a significant increase in atherosclerotic lesion area in the thoracic aorta compared to high-fat diet rabbits without G-CSF.
  • Altered Lipid Profiles: G-CSF accelerated the increase in plasma TC and LDL-C in the early phase of the high-fat diet, though it didn't significantly alter peak levels. TG and HDL-C levels were unaffected by G-CSF in the high-fat diet group.
  • Endothelial Cell Damage: Electron microscopy revealed that G-CSF significantly aggravated endothelial cell damage, deformation, missing cells, and apoptosis in high-fat diet rabbits.
  • Enhanced Apoptosis: TUNEL analysis confirmed that G-CSF significantly increased the number of apoptotic endothelial cells in the thoracic aortae of high-fat diet rabbits and in cultured ECs treated with OX-LDL.
  • ET-1/eNOS Dysregulation: G-CSF treatment in high-fat diet rabbits resulted in increased ET-1 mRNA expression and decreased eNOS mRNA expression in thoracic aortae and cultured ECs.

Limitations and Future Work

  • Dosing Schedule: The study used a more frequent dosing schedule (15 doses over 3 weeks) than typically seen in human clinical trials. While the doses were similar, the frequency might influence the observed effects.
  • Limited Exploration of Mechanisms: The authors acknowledge that they did not explore other potential mechanisms by which G-CSF might influence atherosclerosis.
  • Future Directions: The authors emphasize the need for randomized clinical trials to evaluate the feasibility and safety of G-CSF on coronary artery diseases, particularly in patients with hyperlipidemia. Further research could investigate the precise mechanisms of G-CSF's interaction with the ET-1/eNOS system and explore alternative G-CSF administration strategies or combinations with other therapies.

Summary updated

Abstract

Granulocyte-colony stimulating factor (G-CSF) has been reported to improve the function of infarcted heart, but its effects on atherosclerosis are unclear. Here we examined the effects and the potential mechanisms in the high-fat diet rabbit model. Six-month-old male New Zealand white rabbits, fed a high-cholesterol diet or a normal diet for 10 weeks, were treated with vehicle or G-CSF. G-CSF increased lesion area in the thoracic aorta and the plasma levels of total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) at the early phase in the high-fat diet group. High-fat diet-induced arterial endothelium damage and apoptosis were greatly aggravated by G-CSF treatment. In vivo, G-CSF impaired apoptosis induced by oxidized low density lipoprotein (OX-LDL) but it had little effect on cultured endothelial cells (ECs) with vehicle treatment. Further research revealed that G-CSF promoted the upregulation of endothelin-1 (ET-1) and the downregulation of endothelial nitric oxide synthase (eNOS) of thoracic aortae induced by a high-fat diet. In vitro, the effects of G-CSF on expression of ET-1 and eNOS in cultured ECs were consistent with those in vivo. Our results suggested that G-CSF exacerbates lipid abnormity and endothelium damage in hyperlipidemia rabbits, thereby resulting in the deterioration of atherosclerosis and that the ET-1/eNOS system may regulate the progression.
BibTeX
@article{hu2013granulocyte,
  author = {Zhaohui Hu and Jie Zhang and Aili Guan and Hui Gong and Ming Yang and Guoping Zhang and Jianguo Jia and Hong Ma and Chunjie Yang and Junbo Ge and Yunzeng Zou},
  title = {{Granulocyte Colony-Stimulating Factor Promotes Atherosclerosis in High-Fat Diet Rabbits}},
  journal = {International Journal of Molecular Sciences},
  year = {2013},
  doi = {10.3390/ijms14034805},
}
Figure